Tristan Gueldenpfennig1,2, Alireza Houshmand1, Ole Jung1,3, Mike Barbeck4,5, Stevo Najman6, Sanja Stojanovic6, Tadas Korzinskas1, Ralf Smeets1, Martin Gosau1, Jens Pissarek7, Steffen Emmert3. 1. University Hospital Hamburg-Eppendorf, Hamburg, Germany. 2. Werner Forßmann Hospital Eberswalde, Eberswalde, Germany. 3. Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany. 4. University Hospital Hamburg-Eppendorf, Hamburg, Germany mike.barbeck@icloud.com. 5. BerlinAnalytix GmbH, Berlin, Germany. 6. Department for Cell and Tissue Engineering Institute of Biology and Human Genetics, Faculty of Medicine, University of Niš, Niš, Serbia. 7. Biotrics bioimplants GmbH, Berlin, Germany.
Abstract
BACKGROUND/AIM: A new manufacturing process has been established for the condensation of collagen derived from porcine pericardium to develop a new dental barrier membrane (CPM) that can provide a long barrier functionality. A native collagen membrane (PM) was used as control. MATERIALS AND METHODS: Established in vitro procedures using L929 and MC3T3 cells were used for cytocompatibility analyses. For the in vivo study, subcutaneous implantation of both membrane types in 40 BALB/c mice and established histological, immuno histochemical and histomorphometrical methods were conducted. RESULTS: Both the in vitro and in vivo results revealed that the CPM has a biocompatibility profile comparable to that of the control membrane. The new CPM induced a tissue reaction including more M2-macrophages. CONCLUSION: The CPM is fully biocompatible and seems to support the early healing process. Moreover, the new biomaterial seems to prevent cell ingrowth for a longer period of time, making it ideally suited for GBR procedures. Copyright
BACKGROUND/AIM: A new manufacturing process has been established for the condensation of collagen derived from porcine pericardium to develop a new dental barrier membrane (CPM) that can provide a long barrier functionality. A native collagen membrane (PM) was used as control. MATERIALS AND METHODS: Established in vitro procedures using L929 and MC3T3 cells were used for cytocompatibility analyses. For the in vivo study, subcutaneous implantation of both membrane types in 40 BALB/c mice and established histological, immuno histochemical and histomorphometrical methods were conducted. RESULTS: Both the in vitro and in vivo results revealed that the CPM has a biocompatibility profile comparable to that of the control membrane. The new CPM induced a tissue reaction including more M2-macrophages. CONCLUSION: The CPM is fully biocompatible and seems to support the early healing process. Moreover, the new biomaterial seems to prevent cell ingrowth for a longer period of time, making it ideally suited for GBR procedures. Copyright
Authors: Daniel Rothamel; Frank Schwarz; Martin Sager; Monika Herten; Anton Sculean; Jürgen Becker Journal: Clin Oral Implants Res Date: 2005-06 Impact factor: 5.977
Authors: Bryan N Brown; Jolene E Valentin; Ann M Stewart-Akers; George P McCabe; Stephen F Badylak Journal: Biomaterials Date: 2009-01-01 Impact factor: 12.479
Authors: Daniel Rothamel; Marcel Benner; Tim Fienitz; Arndt Happe; Matthias Kreppel; Hans-Joachim Nickenig; Joachim E Zöller Journal: Head Face Med Date: 2014-03-27 Impact factor: 2.151
Authors: M Barbeck; S E Udeabor; J Lorenz; A Kubesch; J Choukroun; R A Sader; C J Kirkpatrick; S Ghanaati Journal: Ann Maxillofac Surg Date: 2014 Jul-Dec
Authors: Jorge Iván Castro; Carlos Humberto Valencia Llano; Diego López Tenorio; Marcela Saavedra; Paula Zapata; Diana Paola Navia-Porras; Johannes Delgado-Ospina; Manuel N Chaur; José Hermínsul Mina Hernández; Carlos David Grande-Tovar Journal: Molecules Date: 2022-06-06 Impact factor: 4.927
Authors: Larissa Steigmann; Ole Jung; Wolfgang Kieferle; Sanja Stojanovic; Annica Proehl; Oliver Görke; Steffen Emmert; Stevo Najman; Mike Barbeck; Daniel Rothamel Journal: Biomedicines Date: 2020-12-20
Authors: Ole Jung; Bernhard Hesse; Sanja Stojanovic; Christian Seim; Timm Weitkamp; Milijana Batinic; Oliver Goerke; Željka Perić Kačarević; Patrick Rider; Stevo Najman; Mike Barbeck Journal: Int J Mol Sci Date: 2021-11-22 Impact factor: 5.923
Authors: Moritz Alexander Birkelbach; Ralf Smeets; Imke Fiedler; Lan Kluwe; Martin Wehner; Tilmann Trebst; Philip Hartjen Journal: Int J Mol Sci Date: 2020-09-26 Impact factor: 5.923